Research
Explore detailed research summaries, mechanisms of action, and key publications for each peptide in our catalog.
Featured areas: BPC-157 research overview · receptor signaling research.
5 compounds
Body Protection Compound-157, a pentadecapeptide composed of 15 amino acids studied for its interactions with the FAK-paxillin and VEGFR2-Akt-eNOS signaling pathways.
Thymosin Beta-4 fragment studied for its role in cell migration via G-actin sequestration and actin polymerization in preclinical models.
A combined formulation of BPC-157 and TB-500 supplied together in one vial for signaling pathway research in preclinical models.
A four-peptide blend of GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg) and KPV (10mg), supplied together in one lyophilized vial for multi-pathway research studies.
Copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, examined in published in-vitro research on extracellular-matrix gene expression and metalloproteinase activity.
2 compounds
Synthetic GHRH analog peptide studied for GHRH-receptor binding and Gαs/cAMP signaling in pituitary-derived cell systems.
Growth Hormone Releasing Peptide-6, a synthetic hexapeptide studied for its binding to the ghrelin/GHS receptor (GHS-R1a) and GH secretion signaling.
3 compounds
Synthetic peptide used in laboratory research to study incretin receptor binding kinetics and downstream intracellular signaling cascades.
Synthetic peptide studied in laboratory research settings for its receptor binding properties and intracellular signaling characteristics.
Small-molecule, membrane-permeable NNMT inhibitor studied for its effects on the NAD+ salvage pathway and nicotinamide N-methylation in preclinical models.
5 compounds
Mitochondrial-derived peptide encoded within the 12S rRNA gene, studied for AMPK activation and mitochondrial-to-nuclear signaling.
Nicotinamide adenine dinucleotide, a redox coenzyme studied as a cofactor in several hundred enzymatic reactions and as the substrate of sirtuin enzymes.
Cathelicidin-derived 37-amino-acid antimicrobial peptide studied for its interactions with bacterial membranes, immune-cell signaling and epithelial cell signaling in preclinical models.
Mitochondria-targeted tetrapeptide (Szeto-Schiller class) studied for its selective association with cardiolipin on the inner mitochondrial membrane and its effects on electron transport efficiency in preclinical models.
Melanotan II, a cyclic α-MSH analog and non-selective melanocortin receptor agonist (MC1R, MC3R, MC4R, MC5R) studied in melanocortin receptor binding and signaling research.
3 compounds
Synthetic heptapeptide analog of the endogenous immunomodulator tuftsin, studied for GABAergic and monoamine pathway modulation and BDNF expression in preclinical neuroscience models.
Synthetic heptapeptide derived from the ACTH(4-10) fragment, studied for BDNF/NGF expression, monoaminergic signaling, and neurotrophic pathway activity in preclinical models.
DSIP, a naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) examined in published preclinical research on EEG and neuroendocrine signaling.
Vial formats, testing documentation and sourcing details for selected compounds.
For research use only. Not for human consumption.